Ritanserin, a selective 5-HT1/1C antagonist, and negative symptoms in schizophrenia : a placebo-controlled double-blind trial

Saved in:
Bibliographic Details
Published inBritish journal of psychiatry Vol. 163; no. OCT; pp. 451 - 455
Main Authors DUINKERKE, S. J, BOTTER, P. A, JANSEN, A. A. I, VAN DONGEN, P. A. M, VAN HAAFTEN, A. J, BOOM, A. J, VAN LAARHOVEN, J. H. M, BUSARD, H. L. S. M
Format Journal Article
LanguageEnglish
Published Leeds Maney 1993
Subjects
Biological and medical sciences
Medical sciences
Neuropharmacology
Pharmacology. Drug treatments
Psycholeptics: tranquillizer, neuroleptic
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Human
Psychosis
Drug combination
Chemotherapy
Treatment
Neuroleptic
Psychotropic
Negative symptom
Serotonin antagonist
S2 receptor
Schizophrenia
Online AccessGet full text

Cover

More Information
ISSN:0007-1250
1472-1465